Efficient viral vector production is essential for the cost-effective manufacture of cell and gene therapies. Many of the current production workflows are reliant on basal media in batch-mode, which ...
ChromaTan and Landmark Bio Awarded National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) Grant to Advance Intensified Recombinant Adeno-Associated Virus (AAV) Production ...
VintaBio Presents Data Demonstrating High-Efficiency AAV Vector Production Using Proprietary VintaProcess™ at 2025 ASGCT Annual Meeting The hyper-intensified process delivers significant increases in ...
Portuguese researchers have developed the downstream section of a new streamlined production method for an emerging virus class. The team, from Instituto de Biologia Experimental e Tecnológica (iBET), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback